Abstract:We have synthesized cinnamoyl amide type chiral P,olefin ligand and obtained separable diastereomers of 4d and demonstrated Pd-catalyzed asymmetric allylic substitution reactions of indoles using this chiral ligand with high enantioselectivities (up to 98% ee).
“…According to the observed stereochemical outcome and our previous reports, 4,5 we propose a possible stereochemical pathway for the formation of ( S )- 4 as a product. As shown in Scheme 3, Pd II complexes such as W-type A and M-type B intermediates were formed from ligand (a R )-(–)- 1c .…”
Section: Resultssupporting
confidence: 76%
“…The reaction with 2-, 4-, or 5-substituted indoles also gave the corresponding products (S)-4i-m with high enantioselectivities (entries 10-13). According to the observed stereochemical outcome and our previous reports, 4,5 we propose a possible stereochemical pathway for the formation of (S)-4 as a product. As shown in Scheme 3, Pd II complexes such as W-type A and M-type B intermediates were formed from ligand (aR)-(-)-1c.…”
Section: Resultssupporting
confidence: 75%
“…1). We also recently reported N -alkyl- N -cinnamyl type chiral ligands L2 3 and L3 4 with C(aryl)–N(amine) bond axial chirality and an N -cinnamoyl amide type chiral ligand L4 5 with central chirality and C(aryl)–N(amide) bond axial chirality.…”
We synthesized N-alkyl-N-cinnamoyl amide type phosphine-olefin compounds 1 and found axial chirality in a C(aryl)–N(amide) bond in compounds 1 by HPLC analysis using a chiral stationary phase column. We successfully...
“…According to the observed stereochemical outcome and our previous reports, 4,5 we propose a possible stereochemical pathway for the formation of ( S )- 4 as a product. As shown in Scheme 3, Pd II complexes such as W-type A and M-type B intermediates were formed from ligand (a R )-(–)- 1c .…”
Section: Resultssupporting
confidence: 76%
“…The reaction with 2-, 4-, or 5-substituted indoles also gave the corresponding products (S)-4i-m with high enantioselectivities (entries 10-13). According to the observed stereochemical outcome and our previous reports, 4,5 we propose a possible stereochemical pathway for the formation of (S)-4 as a product. As shown in Scheme 3, Pd II complexes such as W-type A and M-type B intermediates were formed from ligand (aR)-(-)-1c.…”
Section: Resultssupporting
confidence: 75%
“…1). We also recently reported N -alkyl- N -cinnamyl type chiral ligands L2 3 and L3 4 with C(aryl)–N(amine) bond axial chirality and an N -cinnamoyl amide type chiral ligand L4 5 with central chirality and C(aryl)–N(amide) bond axial chirality.…”
We synthesized N-alkyl-N-cinnamoyl amide type phosphine-olefin compounds 1 and found axial chirality in a C(aryl)–N(amide) bond in compounds 1 by HPLC analysis using a chiral stationary phase column. We successfully...
“…[7] Besides, the P-Olefin hybrid ligands with axial chirality reported by the Du group [8] and the Zhou group [9] were also proved to be good choice. Recently, the Mino group [10] reported several examples of cinnamoyl amide type and Ntrans-cinnamylaniline type P-Olefin ligands with axial chirality and their applications in asymmetric catalysis, which could furnish the desired product in up to 91 % yield and 98 % ee. An elegant spiro indane-based SMI-PHOX ligands have been developed by Teng and coworkers, which exhibited good catalytic effects to afford the corresponding products with 85-98 % yields and 83-97 % enantioselectivities.…”
The Pd/phosphoramidite‐selenide‐catalyzed highly enantioselective C‐3 allylic alkylation with a wide range of indole nucleophiles have been developed, giving the corresponding products with up to 95% yield and 99% ee.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.